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Abstract
Background: Mechanical chesQ8 t compression devices deliver high-quality chest compressions. Early data suggests that mechanical devices may be
superior to manual chest compressions in adults following an in-hospital cardiac arrest patients. To determine the feasibility of undertaking an
effectiveness trial in this population, we undertook a feasibility randomised controlled trial.
Methods: WeQ9 undertook a multi-centre parallel group feasibility randomised controlled trial (COMPRESS-RCT). Adult in-hospital cardiac arrest
patients that were in a non-shockable rhythm were randomised in a 3:1 ratio to receive mechanical CPR (Jolfe AB/Stryker, Lund, Sweden) or ongoing
manual CPR. Recruitment was led by the clinical cardiac arrest team.
The primary study outcome was the proportion of eligible participants randomised in the study during site operational recruitment hours. Patients were
enrolled under a model of deferred consent. We report data using descriptive statistics, point estimates and 95% confidence intervals.
Results: Over a two-year period, we recruited 127 patients across five UK hospitals. We recruited 55.2% (95% CI 48.5%61.8%) of eligible study
participants in site operational recruitment hours. Most participants were male (n = 76, 59.8%) with a mean age of 72 (95% CI: 69.974.9) years. Median
arrest duration was 18 (IQR 1329) minutes. In patients randomised to mech-CPR, median time from CPR start to device deployment was 11 (IQR 7
15) minutes. ROSC was achieved in 27.6% (n = 35) participants and 4.7% (n = 6) were alive at 30-days.
Conclusion: COMPRESS-RCT identified important factors that preclude progression to an effectiveness trial of mechanical CPR in the hospital setting
in the UK. Findings will inform the design of future in-hospital intra-arrest intervention trials.
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15 Background
16 In the UK, there are approximQ10 ately 35,000 in-hospitals cardiac arrests
17 per year with an overall hospital survival of 18.4%.1 High-quality
18 cardiopulmonary resuscitation (CPR), defibrillation, and reversal of
19 the underlying cause are the mainstay of cardiac arrest treatment.2
20 However, delivery of high-quality CPR in clinical practice is often
21 challenging.35
22 Mechanical chest compression devices (mech-CPR) deliver high-
23 quality CPR.6 In out-of-hospital cardiac arrest, large randomised
24 controlled trials show that mech-CPR is not superior to manual CPR
25 (man-CPR).79 As such, current guidelines recommend against the
26 routine use of mech-CPR.10 In contrast, research on mech-CPR use in
27 the hospital setting has been limited. Small randomised controlled
28 trials and observational studies have produced very low-certainty
29 evidence that mech-CPR use in the hospital setting is associated with
30 improved clinical outcomes.11
31 Based on evidence of mech-CPR use at in-hospital cardiac arrest
32 and uncertainty regarding its effectiveness, we identified a need for a
33 clinical trial to evaluate the effect of the routine use of mech-CPR,
34 compared with man-CPR in adults that sustain an in-hospital cardiac
35 arrest.12,13 In contrast to out-of-hospital cardiac arrest, there have
36 been relatively few trial of intra-arrest interventions for in-hospital
37 cardiac arrests.14 As such, we decided to first test the deliverability of a
38 mech-CPR trial in a feasibility trial.
39 Methods/design
40 We conducted a multi-centre parallel group randomised controlled
41 feasibility trial across five UK hospitals. We randomised in a 3:1 ratio to
42 either mech-CPR or man-CPR. The trial objective was to assess how
43 feasible it would be to deliver an effectiveness mech-CPR trial in the in-
44 hospital cardiac arrest population.
45 The trial was approved by the West Midlands  Coventry and
46 Warwickshire Research Ethics Committee (16/WM/0299). The Health
47 Research Authority Confidentiality Advisory Group approved the
48 processing and transfer of data without consent, under The Health
49 Service (Control of Patient Information) Regulations 2002 (16/CAG/
50 0088). We prospectively registered the trial with the ISRCTN Trial
51 Registry (ISRCTN08233942). We published the protocol in an open-
52 access journal.15 A National Institute for Health Research Post-
53 Doctoral Research Fellowship (PDF-2015-08-109) funded the trial.
54 We conducted in accordance with Medical Research Council
55 (MRC) Good Clinical Practice guidelines, national legislation and
56 University of Warwick Clinical Trials Unit Standard Operating
57 Procedures. The University of Warwick sponsored the trial.
58 During the trial, we amended the primary outcome from proportion
59 of eligible patients randomised to proportion of eligible patients
60 randomised during operational recruitment hours. This change was
61 made on 21st March 2018 (midway through trial recruitment) due to
62 the challenges experienced by some sites in recruiting 24/7. Our
63 ISCTRN registration records this change.
64 Eligibility criteria
65 Adults (age 18) that sustained an in-hospital cardiac arrest were
66 eligible for inclusion if the cardiac arrest was attended by an
67 emergency team trained in the use of mech-CPR and the patient was
68in a non-shockable rhythm at the point of the study eligibility
69assessment. Key exclusion criteria included known pregnancy,
70prisoners, known previous study participation, and cases where
71mech-CPR was contraindicated (for example, patient size) or required
72as part of routine clinical care (for example, cardiac arrest during
73coronary angiography).
74We defined in-hospital cardiac arrest to exclude events in the
75emergency department. We excluded patients in a shockable rhythm
76due to a finding of harm associated with mech-CPR use in this patient
77group in the PARAMEDIC trial.7 This may be attributed to delays in
78defibrillation in the mech-CPR group, although it has not been
79replicated in other trials.16,17
80For a team to be considered trained in the use mech-CPR, at least
81two clinicians were required to be competent in device use. This
82safeguard was implemented as previous research has highlighted that
83mechanical chest compression device deployment can be associated
84with prolonged chest compression pauses.18,19 We took the view that
85ensuring at least two people present were competent in the
86deployment process would mitigate this risk. Our approach was
87informed by our preparatory simulation work.20
88Study interventions
89Following confirmation of cardiac arrest, all patients received man-
90CPR. Following randomisation, the cardiac arrest team deployed the
91mechanical chest compression device (mech-CPR- intervention
92group) or continued to deliver manual CPR (man-CPR- control
93group). All other treatments were delivered in accordance with
94Resuscitation Council (UK) guidelines.21
95A LUCAS-2 or LUCAS-3 mech-CPR device (Jolfe AB/Stryker,
96Lund, Sweden) was deployed as soon as possible following
97randomisation in participants randomised to mech-CPR. Teams were
98trained using a pit-stop approach to minimise pauses in chest
99compression delivery during device deployment through use of a two-
100stage deployment process.20 The target maximum chest compression
101pause during each phase of deployment was ten seconds.
102In patients randomised to the man-CPR arm, participants
103continued to receive manual chest compressions. If available, teams
104were permitted to use a real-time audiovisual feedback device to guide
105man-CPR delivery.
106Outcome measures
107The primary outcome was the proportion of eligible patients
108randomised during site operational recruitment hours.
109Secondary outcomes included a range of measures, grouped as
110study feasibility outcomes, patient outcomes, process outcomes, and
111safety outcomes (Table S1 in Supplementary material). Our patient
112follow-up included an assessment of survival, neurological outcome
113and quality of life at six-months. Patient outcomes were selected to
114comply with the Core Outcome Set for Cardiac Arrest (COSCA)
115statement.22
116Recruitment and randomisation
117We designed the trial to facilitate recruitment 24-h a day by the hospital
118cardiac arrest team.
119On arrival of the mechanical chest compression device at the
120cardiac arrest event, a trained clinician assessed patient trial eligibility.
121Eligible patients proceeded to randomisation. We used a sequentially
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122 numbered sealed opaque tamper-proof envelope randomisation
123 system. A single envelope was stored with each trial device. We
124 randomised eligible patients on an individual basis in a 3:1 ratio in
125 favour of the use of the mech-CPR.
126 We used an unequal randomisation ratio to increase clinician’s
127 potential exposure to mech-CPR use as this would better correlate
128 with exposure if devices were implemented in practice. Our
129 expectation was that this would help to optimise the deployment
130 process and safeguard participants against the potential harm
131 associated with prolonged chest compression pauses during
132 mechanical chest compression device deployment.
133 At the point that an envelope was opened, we categorised the
134 participant as being randomised for the intention-to-treat analysis.
135 One randomisation envelope was stored with each mechanical
136 device. Following envelope use, the next sequentially numbered
137 envelope was allocated to that device. The study statistician
138 generated the randomisation sequence, using the centre as strata
139 and random block sizes to ensure that a 3:1 allocation was maintained
140 for each strata. A staff member at the trial co-ordinating centre, who
141 was independent of the study team, packed the envelopes.
142 Blinding
143 We ensured allocation concealment through the use of an opaque
144 envelope system. We were unable to blind the clinical team as they
145 were required to deliver the clinical intervention. We did not
146 specifically seek to blind all site research teams as the randomisation
147 details were recorded in the patient’s medical record, but requested
148 that a blinded researcher support the participant to complete
149 discharge questionnaires. We also did not blind staff at the trial co-
150 ordinating centre as knowledge of allocated intervention was required
151 for monitoring of compliance. Participants were initially blinded as they
152 would be unconscious due to cardiac arrest. We measured blinding
153 success through study questionnaires in which survivors were asked if
154 they were aware of their allocated treatment intervention.
155 Consent
156 Patients were enrolled in the trial under a deferred consent model, as
157 approved by a Research Ethics Committee, in accordance with
158 English law. We approached participants, or a surrogate decision
159 maker, at the earliest reasonable opportunity following the cardiac
160 arrest event to seek consent for ongoing data collection.
161 Sample size and statistical analysis
162 We planned to recruit for a period of two-years or until we reached
163 330 participants, whichever came first. Feasibility trials typically recruit
164 2550 patients per study arm.23 Our planned target of 330 participants
165 was to ensure sufficient precision in our estimate for the primary
166 outcome and to use the Cocks and Torgerson approach to determine
167 the statistical appropriateness of progression to an effectiveness trial.24
168 For our trial, we estimated a sample size for an effectiveness trial of
169 3554 patients, based on detecting a 3.5% absolute improvement in 30-
170 day survival at a power of 90% and a significance level of 0.05. As such,
171 we determined that 330 patients were required for this feasibility trial
172 (9% of 3554), after accounting for loss to follow-up.24
173 For our statistical analysis, we describe categorical data as
174 frequency and percentage and continuous data as mean and standard
175 deviation or median and interquartile range, depending on normality of
176the data distribution. In our statistical plan, we described plans to
177compare group outcomes, as we would for an effectiveness trial, by
178describing risk ratio and 95% confidence interval or mean difference
179and 95% confidence interval, as appropriate. In addition, for the
180outcome of 30-day survival, we planned to compare groups using an
18180% one-sided confidence interval, as described above. Analyses are
182undertaken on an intention-to-treat basis.
183Results
184Over a two-year period (February 2017 to February 2019),
185COMPRESS-RCT ran at five UK hospitals, of which three hospitals
186recruited patients on a 24/7 basis. Sites screened a total of 936 cardiac
187arrests, of which 662 occurred during site operational recruitment
188hours (figure one). After excluding 432 events for patient reasons, we
189randomised 127 (99 mech-CPR; 28 man-CPR) out of 230 potentially
190eligible patients in cardiac arrest.
191The proportion of patients randomised during operational recruit-
192ment hours was 55.2% (95% confidence interval 48.5%61.8%). In
193total, 38.6% participants were randomised outside normal office hours
194and 74.8% participants had analysable CPR quality data (Table 1;
195Table S2 in Supplementary material). Some feasibility outcomes,
196such as blinding success, are challenging to interpret due to the low
197number of participants that reached that part of the trial.
198Themeanage ofparticipantswas72(95%CI: 69.974.9)yearsand
19959.8% (n = 76) were male (Tables 2 and 3). Most were medical in-
200patients (n = 90, 70.9%) with an initial rhythm of pulseless electrical
201activity (n = 77, 60.6%). Using the GO-FAR score, most participants
202(n = 80, 63.0%) were estimated to have 315% (average) chance of
203survival with good neurological outcome based on pre-arrest factors.25
204Median arrest duration was 18 (IQR 1329) minutes, with median
205time from CPR start to randomisation of 6 min (IQR 410). In patients
206randomised to mech-CPR, median time from CPR start to device
207deployment was 11 (IQR 715) minutes. In the 99 patients
208randomised to mech-CPR, 71.7% (n = 71) received mechanical chest
209compressions. The main reason for not using mech-CPR was return of
210spontaneous circulation prior to deployment (Fig. 1).
211Data on mechanical device deployment were available for 62.9%
212(n = 44) patients that received mech-CPR (Table 4). Mean time to
213deploy the device back plate and upper unit of the device was 7.4 (95%
214CI 6.08.9) and 9.8 (95% CI 7.911.8) seconds respectively. CPR
215quality in both groups adhered, on average, to current guidelines
216(Table 4; Table S3 in Supplementary material).26
Table 1 – Study feasib Q1ility outcomes.
Outcome
Proportion of eligible patients randomised
during site operational recruitment hours
55.2% (95% CI 48.561.8)
n = 127 of 230
Proportion of patients randomised outside of
working hours
38.6% (95% CI 30.147.6)
n = 49 of 127
Proportion of patients/consultees agreeing to
ongoing study participation
77.8% (95% CI 40.097.2)
n = 7 of 9
Percentage of patients with analysable chest
compression quality data
74.8% (95% CI 66.382.1)
n = 95/127
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Table 2 – Participant characteristics.
Mech-CPR (n = 99) Man-CPR (n = 28) All cases (n = 127)
Age (years)  mean (95% CI) 72 (69.575.1) 73 (67.178.4) 72 (69.974.9)
Sex-male  n(%) 60 (60.6) 16 (57.1) 76 (59.8)
Weight (kg)  mean (95% CI) 71.5 (67.775.3) 77.6 (69.685.7) 73.0 (69.576.4)
Height (cm)  mean (95% CI) 167.5 (164.8170.3) 167.3 (162.7172.0) 167.5 (165.2169.8)
Baseline CPC  median (IQR) 1 (12) 1 (11) 1 (11)
Patient category  n(%)
Trauma 9 (9.1%) 2 (7.1%) 11 (8.7%)
Medical 72 (72.7%) 18 (64.3%) 90 (70.9%)
Elective/scheduled surgery 8 (8.1%) 2 (7.1%) 10 (7.9%)
Emergency/urgent surgery 9 (9.1%) 6 (21.4%) 15 (11.8%)
Outpatient 1 (1.0%) 0 (0.0%) 1 (0.8%)
Go-far score-likelihood of survival with good neurological outcome  n(%)
Very low 4 (4.0%) 0 (0.0%) 4 (3.2%)
Low 16 (16.2%) 5 (17.9%) 21 (16.5%)
Average 64 (64.7%) 16 (57.1%) 80 (63.0%)
Above average 15 (15.2%) 7 (25.0%) 22 (17.3%)
Missingness  weight 12 cases (11 mechanical, 1 manual); height 29 cases (24 mechanical, 5 manual).
Table 3 – Cardiac arrest characteristics.
Mech-CPR (n = 99) Man-CPR (n = 28) All cases (n = 127)
Initial rhythm  n(%)
PEA 59 (59.6%) 18 (64.3%) 77 (60.6%)
Asystole 36 (36.4%) 10 (35.7%) 46 (36.2%)
VF/VT 4 (4.0%) 0 (0%) 4 (3.2%)
Rhythm at time of randomization  n(%)
PEA 60 (60.6%) 18 (64.3%) 78 (61.4%)
Asystole 37 (37.4%) 10 (35.7%) 47 (37.0%)
VF/VT 2 (2.0%) 0 (0%) 2 (1.6%)
Arrest monitored  n(%) 42 (42.4%) 14 (50.0%) 56 (44.1%)
Arrest witnessed  n(%) 62 (62.6%) 17 (60.7%) 79 (62.2%)
Cardiac arrest location n(%)
Ward/Emergency Admissions Unit 84 (84.8%) 24 (85.7%) 108 (85.0%)
Coronary Care Unit 4 (4.0%) 1 (3.6%) 5 (3.9%)
Critical Care Unit 3 (3.0%) 2 (7.1%) 5 (3.9%)
Imaging Department 3 (3.0%) 1 (3.6%) 4 (3.1%)
Specialist Treatment Area 2 (2.0%) 0 (0%) 2 (1.6%)
Other 3 (3.0%) 0 (0%) 3 (2.4%)
Surface where CPR performed  n(%)
Foam mattress 59 (59.6%) 18 (64.3%) 77 (60.6%)
Air mattress 23 (23.2%) 5 (17.9%) 28 (22.1%)
Floor 6 (6.1%) 4 (14.3%) 10 (7.9%)
Other 6 1 (3.6%) 7
Unknown 5 (5.1%) 0 (0%) 5 (3.9%)
Mechanical device used  n(%) 71 (71.7%) 0 (0%) 71 (55.1%)
Adrenaline
Administered  n(%) 99 (100%) 26 (92.9%) 125 (98.4%)
Dosage (mg)  median (IQR) 3 (25) 3 (24) 3 (24)
Type of advanced airway  n(%)
Tracheal tube 33 (33.3%) 11 (39.3%) 44 (34.7%)
Supraglottic airway 50 (50.5%) 15 (53.6%) 65 (51.2%)
Not used 16 (16.2%) 2 (7.1%) 18 (14.2%)
Arrest timings  median (IQR)
Arrest duration (CPR start to CPR stop) 19 (1330) 18 (1025) 18 (1329)
CPR start to mechanical device arrival 6 (39) 4 (26) 5 (38)
CPR start to randomisation 7 (411) 5 (37) 6 (410)
CPR start to mechanical compressions 11 (715)  11 (715)
PEA  pulseless electrical activity; VF/VT  ventricular fibrillation/ventricular tachycardia.
Missingness  witnessed 2 cases (2 mechanical); adrenaline dosage 3 cases (3 mechanical); arrest duration 4 cases (4 mechanical); time to device arrival 5 cases
(5 mechanical); time to randomisation 4 cases (4 mechanical); time to first mechanical compression 3 cases (3 mechanical).
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Fig. 1 – Trial CONSORT flow chart.
Table 4 – CPR quality and device deployment metrics.
Mech-CPR (n = 99) Man-CPR (n = 28) All cases (n = 127)
CPR quality  mean (95% CI)
Compression depth (mm)a 59.2 (56.062.3) 59.1 (49.568.8) 59.2 (56.062.3)
Compression rate (/min) 109.0 (107.4110.7) 115.6 (110.5120.6) 110.4 (108.7112.1 )
Flow-fraction 0.86 (0.90.9) 0.89 (0.90.9) 0.87 (0.90.9)
Device deployment  mean (95% CI)
Pause for backplate (seconds) 7.43 (6.08.9)  
Pause for upper part of device (seconds) 9.83 (7.911.8)  
Flow fraction in minute preceding first mechanical compression 0.68 (0.60.7)  
Missingness  CC depth 61 cases (48 mechanical, 13 manual); CC rate 32 cases (24 mechanical; 8 manual); flow-fraction 32 cases (24 mechanical; 8 manual);
device deployment 27 cases.
a CC depth in mech-CPR arm describes CC depth prior to device deployment. CC depth in man-CPR describes depth over entire event.
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217 ROSC was achieved in 27.6% (n = 35) participants (Table 5).
218 Survival to discharge, 30-days and six-months was observed in 3.9%
219 (n = 5), 4.7% (n = 6), and 3.1% (n = 4) participants respectively. All five
220 patients that survived to hospital discharge had a good neurological
221 outcome (n = 5, 3.9%). Length of stay and qualiQ11 ty of life outcomes are
222 reported in Table S4 in the Supplementary material.
223 Four device adverse events were reported, of which none were
224 categorised as serious. In two cases, the device did not start and both
225 events were attributed to human error. In one case, the device did not
226 restart after a rhythm assessment. Following an investigation by the
227 manufacturer and Medicines and Healthcare products Regulatory
228 Agency, a device-related cause could not be identified. In all three
229 cases, manual CPR was immediately recommenced. In the fourth
230 case, skin breakdown at the device compression point was noted.
231 There were a number of protocol deviations during the study,
232 including the 28 participants randomised to mech-CPR who did not
233 receive the intervention (Fig. 1). Two participants were retrospectively
234 identified as having been ineligible at the point of randomisation: one
235 of whom was in a shockable rhythm and one where an insufficient
236 number of trained team members were present. Both were included in
237 the analysis in accordance with intention-to-treat principles. There
238 were two cases in which envelopes were used out of sequence.
239 Discussion
240 In this randomised feasibility trial comparing mech-CPR with manual-
241 CPR in the hospital setting, we recruited 127 patients over a two-year
242 period across five hospitals. We recruited 55% of potentially eligible
243 patients. We observed effective deployment of mech-CPR devices
244 and delivery of high-quality CPR across both study arms. Overall, 30-
245 day survival was 4.7%. Due to lower than planned recruitment, we
246 decided that it would not be informative to either statistically compare
247 groups or make use of the Cocks and Torgerson approach.24
248 Our rationale for undertaking a feasibility trial reflects limited
249 experience in both the UK and internationally of undertaking trials of
250 intra-arrest interventions in the setting of in-hospital cardiac arrest,
251 and the challenge of implementing a new health technology.14 Whilst
252many UK hospitals own mechanical chest compression devices, use
253is typically limited to specific locations, such as the emergency
254department or cardiac catheter laboratory.12
255Our trial demonstrated the feasibility of 24/7 recruitment to a
256randomised controlled trial of an intra-arrest intervention across three
257hospital sites. In the remaining two sites, 24/7 recruitment was
258precluded by frequent changes in cardiac arrest team composition
259and the associated need to train a large number of individuals in device
260use and trial procedures. This is an important finding that will inform
261the design of future in-hospital trials.
262In the specific context of a mech-CPR trial, we identified three key
263challenges that would likely preclude progression to an effectiveness
264trial, namely patient outcome; CPR quality; and overall recruitment.
265Firstly, for patient outcome, weobserved a lower than expected hospital
266survival rate. Study recruits were patients in a non-shockable rhythm
267thathad not respondedto initial resuscitation measures.The implication
268of a low event rate is marked inflation of the sample size required to
269reliably detect a difference between study arms. For example, based on
270a baseline 30-day survival rate of 4.7%, a sample size of over
27120,000 patients would be required to detect a small 1% difference in 30-
272day survival at 90% power and a significance level of 0.05.
273Our original survival projection was based on registry data which
274reported a hospital survival rate of approximately 10% in patients that
275present in a non-shockable rhythm, compared with 45% in patients in a
276shockable rhythm.1,27 Our observed 30-day survival rate of 4.7% is
277likely explained by a combination of our target population (patients in a
278non-shockable rhythm) and the timing of the intervention. Random-
279isation occurred several minutes after arrest onset, by which point
280patients had failed to respond to immediate treatments, such as chest
281compressions, ventilation and oxygenation, and drug therapy.
282Recruitment of patients earlier in their cardiac arrest would have
283resulted in a higher survival rate.28,29 In studies of intra-arrest
284interventions, timeto intervention isan importantdeterminantofoutcome.
285Forexample,ananalysisof thePARAMEDIC-2 trial foundthatadrenaline
286wasmosteffectivewhengiven early in thecardiac arrest.30Cardiac arrest
287observational studies are subject to resuscitation time bias as patients
288with longer cardiac arrests are most likely to receive intra-arrest
289interventions, such as drugs, advanced airways and mech-CPR.31 This
Table 5 – Participant outcomes.
Mech-CPR (n = 99) Man-CPR (n = 28) All cases (n = 127)
ROSC 20 min  n(%) 28 (28.3%) 7 (25.0%) 35 (27.6%)
Survival  n(%)
Hospital discharge  n(%)
4 (4.0%) 1 (3.6%) 5 (3.9%)
30 days  n(%)
5 (5.1%) 1 (3.6%) 6 (4.7%)
6-month  n(%)s
3 (3.0%) 1 (3.6%) 4 (3.1%)
Survival with good neurological outcome (CPC) n(%)
Discharge
4 (4.0%) 1 (3.6%) 5 (3.9%)
Survival with good neurological outcome (mRS) n(%)
Discharge
4 (4.0%) 1 (3.6%) 5 (3.9%)
6-months
1 (1.0%) 0 (0.0%) 1 (0.8%)
ROSC  return of spontaneous circulation; CPC  cerebral performance category; mRS  modified Rankin score.
Missingness  mRS at 6-months 2 cases (1 mechanical; 1 manual).
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290 bias highlights the importance of, wherever feasible, robustly testing
291 treatments in a randomised controlled trial.
292 In this trial, recruitment of patients earlier in the arrest would have
293 beenchallenging toachieveand reducedthe reduced the trial’s external
294 validity. Our approach was to strategically locate 23 devices across
295 each study site to best reflect practice in hospitals that already use
296 mechanical chest compression devices. Arrival of the device at the
297 arrest was required for randomisation. Our median reported time to
298 randomisation was six minutes, although, as this was based on clinician
299 recollection of events, this likely reflects a best-case estimate.32 A
300 deployment model in which a device is located in each clinical area
301 would substantially increase cost, but may have limited effect on time-
302 to-deployment. For example, in an observational study of mechanical
303 device use in the cardiac catheter laboratory where the device was
304 immediately available, median time to device use was 7.4 min.33
305 Secondly, the primary process by which it is proposed mechanical
306 chest compression devices might improve outcome in cardiac arrest is
307 through the optimisation of chest compression delivery. This reflects
308 evidence that delivery of in-hospital CPR is often sub-optimal.3,34 A
309 key risk of mechanical chest compression device use are the pauses
310 associated with deployment.35 Our data on pauses during device
311 deployment compare favourably with published studies, including
312 those in highly optimised systems.18,19 However, in contrast to
313 previous studies, the high quality of CPR that we observed in the
314 manual chest compression arm meant that we did not observe any
315 separation of trial arms in relation to CPR quality.18 Two of the five
316 study hospitals routinely used real-time audiovisual CPR feedback
317 which exceeds the rate reported in the literature.36
318 Thirdly, our overall recruitment was lower than anticipated. This
319 was attributable to a number of system and patient factors, including
320 the challenge of delivering 24/7 recruitment at two of our sites, the
321 incidence of patients in shockable rhythm, and the decision to require
322 two clinicians present trained in device use. These are important
323 issues to consider when designing future trials.
324 Our study has a number of limitations. Firstly, despite the efforts of
325 site teams, we were unable to achieve our planned sample size. This
326 precluded key planned analyses, although we were able to base our
327 decision that an effectiveness trial is not feasible on other findings.
328 Secondly, we pragmatically selected study sites based on their
329 willingness to participate. We do not know how representative these
330 sites are of other UK hospitals. Across these sites, there was variability
331 in use of real-time audiovisual feedback and previous experience with
332 mech-CPR, which reflects variability across UK hospitals.12 Thirdly,
333 compliance in the mech-CPR arm was 72%. Non-compliance was
334 typically due to ROSC, but a number of other reasons were recorded
335 including a decision that ongoing resuscitation was futile.
336 In this multi-centre feasibility randomised controlled trial, we
337 identified specific challenges that preclude progression to an
338 effectiveness trial of mech-CPR. These challenges were predomi-
339 nantly attributable to the challenge of implementing a new technology
340 safely in the context of a clinical trial. Our findings demonstrate that
341 recruitment to a randomised controlled trial of an intra-arrest
342 intervention is feasible and highlight key issues that will require
343 consideration in designing trials of other interventions.
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